EU Clinical Trial 2017-003619-20

Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes  Feb 11, 2019

Main objective of the trial: The primary objective is to assess the long-term effects of treatment with semaglutide compared to placebo, both added to standard-of-care, on diabetic retinopathy development and progression in subjects with T2D El objetivo principal es evaluar los efectos a largo plazo del tratamiento con semaglutida en comparación con placebo, ambos añadidos al tratamiento de referencia, sobre la aparición y la progresión de la retinopatía diabética en sujetos con DT2.

Parties

Sponsors
Countries
BR CA EU IL IN MX RS RU US
Keywords
Ozempic® Type II diabetes mellitus semaglutide

JSON preview

Similar records

Title

Source:  EMA Last updated:  Jun 5, 2019

From ClinicalTrialsRegister.eu, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.